Dietz, S., Christopoulos, P., Yuan, Z., Angeles, A. K. J., Gu, L., Volckmar, A., . . . Sültmann, H. (2020). Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. EBioMedicine, 62(12), . https://doi.org/10.1016/j.ebiom.2020.103103
Chicago-Zitierstil (17. Ausg.)Dietz, Steffen, et al. "Longitudinal Therapy Monitoring of ALK-positive Lung Cancer by Combined Copy Number and Targeted Mutation Profiling of Cell-free DNA." EBioMedicine 62, no. 12 (2020). https://doi.org/10.1016/j.ebiom.2020.103103.
MLA-Zitierstil (9. Ausg.)Dietz, Steffen, et al. "Longitudinal Therapy Monitoring of ALK-positive Lung Cancer by Combined Copy Number and Targeted Mutation Profiling of Cell-free DNA." EBioMedicine, vol. 62, no. 12, 2020, https://doi.org/10.1016/j.ebiom.2020.103103.